MedTrace Logo

Evaluation of 3D Ultrasound in Brain Tumor Surgery

NCT05956977 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2023-07-24

No results posted yet for this study

Summary

Evaluation of impact of use of 3D ultrasound in brain tumor surgery on extend of resection. Benefit for surgery, neurological outcome, accuracy and image quality are secondary outcome parameters. Control group is a retrospective matched pair cohort.

Conditions

  • Residual Tumor

Interventions

DEVICE

resection with help of 3D ultrasound

see above

Sponsors & Collaborators

  • Brainlab AG

    collaborator INDUSTRY

  • University of Ulm

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2024-12-01
Completion
2025-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05956977 on ClinicalTrials.gov